Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the NHANES III (1988-1994) [0.03%]
12种胰岛素抵抗替代标志物与代谢功能障碍相关脂肪肝病风险和全因死亡率的关系：来源于NHANES III（1988-1994）数据的研究
Zhengyuan Yue,Yang Zhang,Jiahao Zhang et al.
Zhengyuan Yue et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has been shown to be intimately linked to the presence of insulin resistance. This study aimed to comprehensively evaluate 12 insulin resistance...
Positive conversion of latent tuberculosis screening in patients with inflammatory bowel disease on antitumor necrosis factor alpha drugs: a systematic review and meta-analysis [0.03%]
抗肿瘤坏死因子α药物治疗的炎症性肠病患者潜伏结核感染阳性转换的系统评价和.meta.分析
Helio Rzetelna,Paula Santo,Heitor Siffert Pereira de Souza et al.
Helio Rzetelna et al.
Inflammatory bowel disease (IBD) patients undergoing antitumor necrosis factor-alpha (anti-TNF) therapy are at increased risk of developing tuberculosis (TB), making screening before anti-TNF initiation mandatory. Repeated screening during ...
Chest X-ray prior to biological treatment in inflammatory bowel diseases: it is not only about tuberculosis - a case report and literature review [0.03%]
生物制剂治疗炎症性肠病前胸部X线检查不仅为了排除结核-一例报告及文献复习
Ida Malene Hagbard Binder,Jørn Brynskov,Mohamed Attauabi
Ida Malene Hagbard Binder
Background: Biological treatments have substantially improved management of inflammatory bowel disease, but their profound immunosuppressive effects necessitate infection screening before initiation. Current guidelines re...
Comprehensive management of modifiable factors and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease [0.03%]
全面管理代谢功能障碍相关肝脂肪变的可改变因素与全因死亡率的关系
Jingdan Zhang,Bingbing Wang,Zeran Wang et al.
Jingdan Zhang et al.
Background and aims: To assess the association between comprehensive control of modifiable factors and all-cause mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) patients, explore effect modif...
Adjuvant camrelizumab for hepatocellular carcinoma patients with high risk of recurrence after curative hepatectomy: a retrospective multicenter study [0.03%]
卡瑞利珠单抗辅助治疗肝癌手术后高复发风险患者的疗效分析——一项多中心回顾性研究
Lei-Po Lin,Jia-Yong Su,Xiao-Feng Dong et al.
Lei-Po Lin et al.
Background and aims: The role of adjuvant programmed cell death-1 (PD-1) inhibitors following curative hepatectomy in patients with hepatocellular carcinoma (HCC) at high risk of recurrence remains controversial. This stu...
Clinical presentation, anti-tTG IgA levels, and histological severity in adult celiac disease [0.03%]
成人乳糜泻的临床表现、抗组织型转谷氨酰胺酶IgA水平及其与病理严重程度的关系
Gonca Karakan,Banu Böyük,Hande Erman et al.
Gonca Karakan et al.
Background: Adult celiac disease may present with atypical or nonspecific symptoms. Although the diagnostic value of anti-tissue transglutaminase IgA (anti-tTG IgA) in relation to histological severity has been well-estab...
Medication adherence level and its predictors among inflammatory bowel disease sufferers in a resource-strained healthcare setting [0.03%]
资源匮乏的医疗环境下炎症性肠病患者的用药依从性及其影响因素
Woretaw S Zewdu,Tigabu E Zerihun,Zemen A Emiru et al.
Woretaw S Zewdu et al.
Background: Despite novel breakthroughs in the inflammatory bowel disease (IBD) therapeutics armamentarium, nonadherence remains an invisible epidemic. However, its prevalence and determining features were unknown within ...
Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel disease [0.03%]
阿达木单抗的药物清除率较低与炎症性肠病患者的主动血药浓度监测和黏膜愈合有关
Tina Deyhim,Alessandra Saraga,Ajay Gade et al.
Tina Deyhim et al.
Objectives: There are limited data regarding adalimumab (ADM) clearance in inflammatory bowel disease (IBD). The aim of this study was to identify factors associated with ADM clearance and to assess its association with m...
Investigating aspirin and post-colonoscopy colorectal cancer and cancer-specific mortality risk: a Swedish Register Study 2007-2016 [0.03%]
一项关于阿司匹林和结肠镜检查后的结直肠癌风险及癌症特异性死亡率的瑞典登记研究（2007-2016年）
Anna Forsberg,Linnea Widman,Anna Andreasson
Anna Forsberg
Objective: Acetylsalicylic acid (ASA) has been linked to reduced incidence and mortality in colorectal cancer (CRC), although its sex-specific effects remain unclear. Post-colonoscopy colorectal cancer (PCCRC), is a CRC d...
Burden of premature mortality from colorectal cancer among Asian Americans: years of life lost analysis [0.03%]
亚裔美国人结直肠癌过早死亡疾病负担：损失的生命年分析
Muhammad Ali Tariq,Aiman Fatima Malik
Muhammad Ali Tariq